근접방사선치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 용도별, 선량 유형별(고선량률, 저선량률), 지역별, 경쟁별(2020-2030년)

The Global Brachytherapy Market, valued at USD 1.06 Billion in 2024, is projected to experience a CAGR of 7.4% to reach USD 1.63 Billion by 2030. Brachytherapy is a specialized form of internal radiation therapy involving the precise placement of encapsulated radioactive sources directly within or immediately adjacent to a target tumor volume. This highly localized treatment delivers potent radiation doses while minimizing exposure to surrounding healthy tissues, thereby improving treatment efficacy and patient outcomes.

Key Market Drivers

The global brachytherapy market is significantly influenced by the increasing worldwide cancer burden. As cancer incidence continues its upward trajectory across various demographics, the demand for effective, localized treatment modalities like brachytherapy intensifies. According to the International Agency for Research on Cancer's Global Cancer Observatory, in February 2024, prostate cancer was the fourth most commonly occurring cancer worldwide with 1.5 million new cases in 2022.

Key Market Challenges

The substantial initial capital investment required for specialized equipment and facilities, coupled with the critical need for a highly skilled workforce, represents a significant impediment to the global brachytherapy market's expansion. This financial barrier limits the establishment of new brachytherapy centers and constrains existing facilities from upgrading to advanced technologies. The specialized nature of brachytherapy necessitates considerable upfront expenditure for afterloaders, treatment planning systems, and dedicated shielded rooms, presenting a challenging economic hurdle for healthcare providers aiming to integrate or enhance this treatment modality.

Key Market Trends

The emergence of artificial intelligence in brachytherapy treatment planning is significantly advancing the market by enhancing precision and efficiency. AI algorithms are streamlining complex tasks such as organ at risk contouring and dose optimization, which traditionally required considerable manual effort. The European Society for Radiotherapy and Oncology Congress Report from 2024 highlighted how AI-driven auto-segmentation reduced delineation time by half in cervical cancer brachytherapy and substantially decreased overall planning times with systems like BiCycle.

Key Market Players

• Varian Medical Systems, Inc.
• Becton Dickinson & Company
• Elekta AB
• Isoray Medical, Inc.
• Eckert & Ziegler BEBIG
• iCAD, Inc.
• CIVCO Medical Solutions
• Theragenics Corporation
• Argon Medical Devices, Inc.
• Carl Zeiss Meditec AG

Report Scope:

In this report, the Global Brachytherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brachytherapy Market, By Product:

• Seeds
• Applicators & Afterloaders
• Electronic Brachytherapy

Brachytherapy Market, By Application:

• Prostate Cancer
• Gynecological Cancer
• Breast cancer
• Others

Brachytherapy Market, By Dosage Type:

• High-Dose Rate (HDR)
• Low-Dose Rate (LDR)

Brachytherapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Brachytherapy Market.

Available Customizations:

Global Brachytherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brachytherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy)
  • 5.2.2. By Application (Prostate Cancer, Gynecological Cancer, Breast cancer, Others)
  • 5.2.3. By Dosage Type (High-Dose Rate (HDR), Low-Dose Rate (LDR))
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Brachytherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Dosage Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Brachytherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Dosage Type
  • 6.3.2. Canada Brachytherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Dosage Type
  • 6.3.3. Mexico Brachytherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Dosage Type

7. Europe Brachytherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Dosage Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Brachytherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Dosage Type
  • 7.3.2. France Brachytherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Dosage Type
  • 7.3.3. United Kingdom Brachytherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Dosage Type
  • 7.3.4. Italy Brachytherapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Dosage Type
  • 7.3.5. Spain Brachytherapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Dosage Type

8. Asia Pacific Brachytherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Dosage Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Brachytherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Dosage Type
  • 8.3.2. India Brachytherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Dosage Type
  • 8.3.3. Japan Brachytherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Dosage Type
  • 8.3.4. South Korea Brachytherapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Dosage Type
  • 8.3.5. Australia Brachytherapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Dosage Type

9. Middle East & Africa Brachytherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Dosage Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Brachytherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Dosage Type
  • 9.3.2. UAE Brachytherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Dosage Type
  • 9.3.3. South Africa Brachytherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Dosage Type

10. South America Brachytherapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Dosage Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Brachytherapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Dosage Type
  • 10.3.2. Colombia Brachytherapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Dosage Type
  • 10.3.3. Argentina Brachytherapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Dosage Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Brachytherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Varian Medical Systems, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton Dickinson & Company
• 15.3. Elekta AB
• 15.4. Isoray Medical, Inc.
• 15.5. Eckert & Ziegler BEBIG
• 15.6. iCAD, Inc.
• 15.7. CIVCO Medical Solutions
• 15.8. Theragenics Corporation
• 15.9. Argon Medical Devices, Inc.
• 15.10. Carl Zeiss Meditec AG

16. Strategic Recommendations

17. About Us & Disclaimer